论文部分内容阅读
目的:探讨并研究头孢曲松和头孢克肟胶囊胶囊治疗下呼吸道感染的临床疗效。方法:选取我院于2012年9月-2014年1月所收治的90例下呼吸道感染患者,基于患者住院的先后顺序,将其划分为对照组与观察组,两组病例分别为45例,其中对照组采取单用头孢曲松来予以静脉滴注治疗,观察组患者则予以头孢曲松和头孢克肟胶囊来予以治疗,对比分析两组患者治疗情况和皮疹发生情况。结果:经过治疗,观察组治疗总有效率为95.6%,对照组治疗总有效率为88.9%,两组治疗效果所存差异不显著,无统计学意义,即P>0.05。在皮疹发生上,观察组有2例出现轻度皮疹,其发生率为4.4%,对照组有7例出现轻度皮疹,其发生率为15.6%,二者所存差异具有统计学意义,即P<0.05。结论:从本次研究所获结果的分析可知,在下呼吸道感染的临床治疗中利用头孢曲松和头孢克肟胶囊治疗,所获治疗效果显著,不仅可加速患者的康复,同时在一定程度上还可减少治疗费用,在临床中具有一定的应用价值以及推广价值。
Objective: To study and study the clinical efficacy of ceftriaxone and cefixime capsules in the treatment of lower respiratory tract infections. Methods: Ninety patients with lower respiratory tract infection in our hospital from September 2012 to January 2014 were selected and divided into control group and observation group based on the order of hospitalization. The two groups were 45 cases, The control group was treated with ceftriaxone alone, and the patients in the observation group were given ceftriaxone and cefixime capsules for treatment. The treatment and rash of the two groups were compared. Results: After treatment, the total effective rate was 95.6% in the observation group and 88.9% in the control group. There was no significant difference between the two groups in the treatment effect (P> 0.05). In the rash occurred, the observation group had 2 cases of mild rash, the incidence was 4.4%, 7 cases in the control group mild rash, the incidence was 15.6%, the difference between the two statistically significant, P <0.05. CONCLUSIONS: From the analysis of the results obtained in this study, it is evident that the use of ceftriaxone and cefixime capsules in the clinical management of lower respiratory tract infections resulted in a significant therapeutic effect, which not only accelerated the recovery of patients but also to a certain extent Can reduce the cost of treatment, has a certain clinical value in the application and promotion of value.